PURPOSE
The purpose of the award is to develop clinical and procedural skills as well as mentoring relationships between trainees and HS experts that might not otherwise be possible due to distance or funding.
PROGRAM - MENTORED EDUCATIONAL EXPERIENCE
The HSF aims to foster the care of patients with HS and careers that include HS-related clinical care, research, and/or teaching. Awardees will learn to manage patients with HS under the mentorship and direction of an HSF member. Awardees may also discuss opportunities to conduct and publish research related to HS.
The HSF invites Residents, Post-Dermatology Residency Fellows, and Faculty to apply for the HSF Mentorship Award. Priority will be given to practitioners applying from states without an HS clinic. If selected, awardees will receive up to $4,000 for direct expenses associated with spending up to 4 weeks working in-person and being mentored by an HSF member. The four weeks of mentorship does not have to be consecutive but must include a minimum of ten days on site with the mentor (the remaining time may take place as remote mentorship).
Prior to arriving for the in-person portion of the mentored educational experience, the awardee and mentor will work together to tailor an experience that will match the awardee’s interests. During the in-person experience, awardees will spend time learning and collaboratively working with their mentor to provide outpatient, procedural, and/or inpatient care with a focus on HS management. Throughout the experience, awardees will also spend time reviewing, critiquing, and synthesizing the medical literature as well as participate in quality improvement and/or research projects with their mentor, which may result in publications. In addition, awardees may participate in didactics (educational conferences) held at the mentor’s location and assist with general dermatology outpatient clinical care.
PROGRAM REQUIREMENTS
BUDGET GUIDELINES
APPLICATION CHECKLIST
Mentorship Award Application Form (see below)
Statement of Purpose (1 page limit, Arial font 11pt or larger, single spaced, 0.5” inch margins) including:
UPON SUCCESSFUL APPLICATION
UPON COMPLETION OF MENTORSHIP EXPERIENCE
These rankings synthesize HSF's published review criteria for its Danby and Translational Research Grant Programs. They are not official numerical weights.
★★★★★
Direct relevance to hidradenitis suppurativa — Critical
The research must address HS specifically, its causes, disease activity, inflammation, complications, diagnosis, treatment or patient outcomes. General dermatology research without a clear HS connection is a weaker fit.
hs-foundation.org
+1
★★★★★
Innovation and scientific novelty — Critical
Propose a new hypothesis, mechanism, biomarker, diagnostic approach or treatment strategy that could advance understanding or management of HS.
★★★★★
Potential to improve patient care — Critical
Explain how findings could improve disease control, reduce pain or tunnel formation, improve diagnosis, guide treatment decisions or address other important burdens experienced by people with HS.
★★★★★
Rigor of research strategy and analysis — Critical
Present clear aims, suitable methods, appropriate controls or comparison groups, meaningful endpoints and a defensible analysis plan. HSF explicitly identifies the quality of the strategy, methodology and analyses as a review criterion.
hs-foundation.org
+1
★★★★☆
Feasibility and contingency planning — Very high
Demonstrate that the aims can be completed within the one-year project period. Identify potential problems, alternative strategies and objective benchmarks for success.
★★★★☆
Investigator capability and career-stage fit — Very high
Show that the principal investigator has the relevant skills, institutional support and responsibility to conduct the research. HSF encourages early-stage investigators, especially for its Danby and Translational Research programs.
hs-foundation.org
+1
★★★★☆
Patient and caregiver involvement — Very high for translational awards
Incorporate input from people living with HS and/or caregivers into study conception, design and interpretation or completion. This is explicitly included in the Translational Research Grant review criteria.
hs-foundation.org
★★★★☆
Potential for future external funding — Very high
For translational awards, show how results could generate the preliminary data needed for larger NIH or other external funding. Outline the next grant or research stage that the award would enable.
hs-foundation.org
+1
★★★☆☆
Diversity of the research team and patient cohort — High
Explain whether the study population adequately represents the intended HS population and whether the team has the complementary expertise needed to carry out the project. Both HSF grant programs list diversity among their review considerations.
hs-foundation.org
+1
★★★★☆
Eligibility and application compliance — Essential gate
Confirm U.S.-based investigator eligibility for the Danby and Translational Research programs, institutional eligibility, the correct application format, direct-cost limits and deadline. Applications must also meet reporting and research-presentation requirements.
hs-foundation.org
+1
| Rank | Predictor | Importance |
|---|---|---|
| 1 | Direct HS relevance | Critical |
| 2 | Innovation | Critical |
| 3 | Patient-care impact | Critical |
| 4 | Methodological rigor | Critical |
| 5 | Feasibility and contingency planning | Very high |
| 6 | Investigator capability | Very high |
| 7 | Patient/caregiver input | Very high for Translational awards |
| 8 | Potential for future funding | Very high |
| 9 | Team and cohort diversity | High |
| 10 | Eligibility and compliance | Essential gate |
Eligible Countries:
Sponsor Institute/Organizations: Hidradenitis Suppurativa Foundation
Sponsor Type: Corporate/Non-Profit
Address: 964 High House Road, #3064, Cary, NC 27513
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 31, 2027
$4,000
Affiliation: Hidradenitis Suppurativa Foundation
Address: 964 High House Road, #3064, Cary, NC 27513
Website URL: https://www.hs-foundation.org/hsf-mentored-experience-grant
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.